July 8 (UPI) -- Older women carrying excess weight have a higher risk of a life-threatening double-whammy, a new study says.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

As a longtime business owner in North Carolina and someone who’s worked closely with employers across the hospitality and ...

Slashing health care support for low-income Californians isn’t just a budget decision, it is a public health crisis in the ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Bob Powell: Well, Wegovy can no longer be used for weight loss reasons under Medicare. And here to talk with me about that is Jae Oh, author of Maximize Your Medicare.

Generally, Medicare does not cover certain medications, such as glucagon-like peptide-1 (GLP-1) receptor agonists, for treating weight loss alone. That said, this may be changing.

The injectable drugs have exploded in popularity due to the potentially life-changing weight loss that some patients experience.

Medicare currently covers drugs that are used for weight loss, like Mounjaro and Ozempic, but only when they are prescribed by doctors for other reasons like managing diabetes. Drugs like Novo ...